Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment.
Mazzaferro
V
V
Department of Surgery, Gastrointestinal Surgery and Liver Transplantation Unit, Pathology Unit, National Cancer Institute, Milan, Italy.
Tagger
A
A
Schiavo
M
M
Regalia
E
E
Pulvirenti
A
A
Ribero
M L
ML
Coppa
J
J
Romito
R
R
Burgoa
L
L
Zucchini
N
N
Urbanek
T
T
Bonino
F
F
D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000517:prevention & control*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control* / Q000821:virology; D011994:Recombinant Proteins; D055502:Secondary Prevention
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins